Cargando…
Natural antisense transcripts in diseases: From modes of action to targeted therapies
Antisense transcription is a widespread phenomenon in mammalian genomes, leading to production of RNAs molecules referred to as natural antisense transcripts (NATs). NATs apply diverse transcriptional and post‐transcriptional regulatory mechanisms to carry out a wide variety of biological roles that...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838512/ https://www.ncbi.nlm.nih.gov/pubmed/29341438 http://dx.doi.org/10.1002/wrna.1461 |
_version_ | 1783304274474696704 |
---|---|
author | Wanowska, Elżbieta Kubiak, Magdalena Regina Rosikiewicz, Wojciech Makałowska, Izabela Szcześniak, Michał Wojciech |
author_facet | Wanowska, Elżbieta Kubiak, Magdalena Regina Rosikiewicz, Wojciech Makałowska, Izabela Szcześniak, Michał Wojciech |
author_sort | Wanowska, Elżbieta |
collection | PubMed |
description | Antisense transcription is a widespread phenomenon in mammalian genomes, leading to production of RNAs molecules referred to as natural antisense transcripts (NATs). NATs apply diverse transcriptional and post‐transcriptional regulatory mechanisms to carry out a wide variety of biological roles that are important for the normal functioning of living cells, but their dysfunctions can be associated with human diseases. In this review, we attempt to provide a molecular basis for the involvement of NATs in the etiology of human disorders such as cancers and neurodegenerative and cardiovascular diseases. We also discuss the pros and cons of oligonucleotide‐based therapies targeted against NATs, and we comment on state‐of‐the‐art progress in this promising area of clinical research. WIREs RNA 2018, 9:e1461. doi: 10.1002/wrna.1461 1.. RNA in Disease and Development > RNA in Disease; 2.. Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs; 3.. RNA Interactions with Proteins and Other Molecules > Small Molecule–RNA Interactions; |
format | Online Article Text |
id | pubmed-5838512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58385122018-03-12 Natural antisense transcripts in diseases: From modes of action to targeted therapies Wanowska, Elżbieta Kubiak, Magdalena Regina Rosikiewicz, Wojciech Makałowska, Izabela Szcześniak, Michał Wojciech Wiley Interdiscip Rev RNA Advanced Reviews Antisense transcription is a widespread phenomenon in mammalian genomes, leading to production of RNAs molecules referred to as natural antisense transcripts (NATs). NATs apply diverse transcriptional and post‐transcriptional regulatory mechanisms to carry out a wide variety of biological roles that are important for the normal functioning of living cells, but their dysfunctions can be associated with human diseases. In this review, we attempt to provide a molecular basis for the involvement of NATs in the etiology of human disorders such as cancers and neurodegenerative and cardiovascular diseases. We also discuss the pros and cons of oligonucleotide‐based therapies targeted against NATs, and we comment on state‐of‐the‐art progress in this promising area of clinical research. WIREs RNA 2018, 9:e1461. doi: 10.1002/wrna.1461 1.. RNA in Disease and Development > RNA in Disease; 2.. Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs; 3.. RNA Interactions with Proteins and Other Molecules > Small Molecule–RNA Interactions; John Wiley & Sons, Inc. 2018-01-17 2018 /pmc/articles/PMC5838512/ /pubmed/29341438 http://dx.doi.org/10.1002/wrna.1461 Text en © 2018 The Authors. WIREs RNA published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Advanced Reviews Wanowska, Elżbieta Kubiak, Magdalena Regina Rosikiewicz, Wojciech Makałowska, Izabela Szcześniak, Michał Wojciech Natural antisense transcripts in diseases: From modes of action to targeted therapies |
title | Natural antisense transcripts in diseases: From modes of action to targeted therapies |
title_full | Natural antisense transcripts in diseases: From modes of action to targeted therapies |
title_fullStr | Natural antisense transcripts in diseases: From modes of action to targeted therapies |
title_full_unstemmed | Natural antisense transcripts in diseases: From modes of action to targeted therapies |
title_short | Natural antisense transcripts in diseases: From modes of action to targeted therapies |
title_sort | natural antisense transcripts in diseases: from modes of action to targeted therapies |
topic | Advanced Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838512/ https://www.ncbi.nlm.nih.gov/pubmed/29341438 http://dx.doi.org/10.1002/wrna.1461 |
work_keys_str_mv | AT wanowskaelzbieta naturalantisensetranscriptsindiseasesfrommodesofactiontotargetedtherapies AT kubiakmagdalenaregina naturalantisensetranscriptsindiseasesfrommodesofactiontotargetedtherapies AT rosikiewiczwojciech naturalantisensetranscriptsindiseasesfrommodesofactiontotargetedtherapies AT makałowskaizabela naturalantisensetranscriptsindiseasesfrommodesofactiontotargetedtherapies AT szczesniakmichałwojciech naturalantisensetranscriptsindiseasesfrommodesofactiontotargetedtherapies |